1Fujii GY,De Juan E jr,Humayun MS,et al.A new 25-gauge instrument system for transconjunctival sutureless vitrectomy surgery[J].Ophthalmology,2002,109:1807-1813.
2Au Eong KG,Fujii GY.A new three-port cannular system for closed pars plana vitrectomy[J].Retina,2002,22:130-132.
3Fujii GY,De Juan E jr,Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery[J].Ophthalmology,2002,109:1814-1820.
5Cheng YY, Pels E, Nuijts RM. Femtosecond-laser-assisted Descemet's stripping endothelial keratoplasty[J]. J Cataract Refract Surg, 2007,33(2):152-155.
6Gomi F,Sawa M,Sakaguchi H, et al. Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy[J]. Br J Ophthalmol, 2008, 92(1):70-73.
7Wu L, Martinez--Gastellanos MA, Quiroz-Mercado H, et al. Twelve-month safety of intravitreal injections of bevacizumab (Avastin-R) : results of the Pan-American Collaborative Retina Study Group(PACORES)[J]. Graefes Arch Clin Exp Ophthalmol, 2008, 246(1) :81-87.
8Arevalo JF, Maia M, Flyrm HW, et al. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy[J]. Br J Ophthalmol, 2008, 92(3) :213-216.
9Gaueher D, Chiappore JA, Paques M, et al. Microglial changes occur without neural cell death in diabetic retinopathy[J]. Vision RES, 2007, 47(6): 612-623.
